☆ 4.8 Editorial Material

Mortality Reduction with Low-Dose CT Screening for Lung Cancer

NEW ENGLAND JOURNAL OF MEDICINE (2020)

期刊

NEW ENGLAND JOURNAL OF MEDICINE

卷 382, 期 6, 页码 572-573

出版社

MASSACHUSETTS MEDICAL SOC

DOI: 10.1056/NEJMe1916361

关键词

类别

Medicine, General & Internal

资金

Department of Health [09/61/01] Funding Source: Medline

向作者/读者索取更多资源

Protocol

社区支持

Reagent

社区支持

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

主要评分

4.8

评分不足

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

Bronchiectasis in Low-Dose CT Screening for Lung Cancer

Qiang Cai, Natthaya Triphuridet, Yeqing Zhu, Nan You, Rowena Yip, David F. Yankelevitz, Claudia Henschke

Summary: Bronchiectasis is prevalent in smokers undergoing low-dose CT screening, and the occurrence of respiratory symptoms and acute events increases with the severity of the Early Lung and Cardiac Action Program Bronchiectasis score.

RADIOLOGY (2022)

添加到收藏夹

Review Oncology

Hesitancy around low-dose CT screening for lung cancer

J. L. Dickson, C. Horst, A. Nair, S. Tisi, R. Prendecki, S. M. Janes

Summary: Lung cancer is the leading cause of cancer death worldwide, with early detection playing a crucial role in improving survival rates. Studies have shown that low-dose computed tomography can significantly reduce lung cancer-specific mortality. Despite some barriers and concerns, this screening method should still be widely promoted.

ANNALS OF ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Characteristics and Outcomes of Lung Cancers Detected on Low-Dose Lung Cancer Screening CT

Eric W. Zhang, Jo-Anne O. Shepard, Anderson Kuo, Wariya Chintanapakdee, Florence Keane, Justin F. Gainor, Mari Mino-Kenudson, Michael Lanuti, Inga T. Lennes, Subba R. Digumarthy

Summary: The study investigated the characteristics and outcomes of screening-detected lung cancers, and found that LCS implementation achieved a higher cancer detection rate, detection of early-stage cancers, and more multifocal lung cancers compared with the NLST, with low complications and mortality.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2021)

添加到收藏夹

Article Respiratory System

Telephone risk-based eligibility assessment for low-dose CT lung cancer screening

Jennifer L. Dickson, Helen Hall, Carolyn Horst, Sophie Tisi, Priyam Verghese, Anne-Marie Mullin, Jonathan Teague, Laura Farrelly, Vicky Bowyer, Kylie Gyertson, Fanta Bojang, Claire Levermore, Tania Anastasiadis, Karen Sennett, John McCabe, Anand Devaraj, Arjun Nair, Neal Navani, Matthew E. J. Callister, Allan Hackshaw, Samantha L. Quaife, Sam M. Janes

Summary: Telephone-based risk assessment is an efficient method to optimize selection for lung cancer screening appointments, but further adjustments are needed to ensure fairness, especially for younger individuals and minority ethnic groups.

THORAX (2022)

添加到收藏夹

Article Medicine, General & Internal

Swiss Pilot Low-Dose CT Lung Cancer Screening Study: First Baseline Screening Results

Lisa Jungblut, Harry Etienne, Caroline Zellweger, Alessandra Matter, Miriam Patella, Thomas Frauenfelder, Isabelle Opitz

Summary: This pilot study in Switzerland assesses the implementation and performance of low-dose CT lung cancer screening and explores its potential impact on reducing mortality rates. The study enrolls participants meeting specific criteria and uses LDCT scans for assessment. Preliminary results suggest the feasibility of LDCT lung cancer screening in Switzerland.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Gastroenterology & Hepatology

Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients

Meylin Caballeros Lam, Paula Pujols, Ana Ezponda Casajus, Fernando Guillen Valderrama, Maria Jose Garcia Velloso, Alejandra Wyss, Loreto Garcia del Barrio, Javier Larrache Latasa, Jesus Pueyo Villoslada, Maria Dolores Lozano Escario, Juan P. de-Torres, Ana Belen Alcaide Ocana, Aranzazu Campo Ezquibela, Luis Seijo Maceiras, Luis Montuenga Badia, Javier Zulueta, Mercedes Inarrairaegui Bastarrica, Ignacio Herrero Santos, Gorka Bastarrika Aleman

Summary: In this study, a lung cancer screening program was implemented in liver transplant recipients (LTR) using low-dose CT and F-18-fluorodeoxyglucose positron emission tomography (FDG-PET). The results showed that 9.7% of the LTR were diagnosed with lung cancer, most of which were non-small cell subtype. The majority of lung cancers (82.3%) were diagnosed at stage I, indicating the effectiveness of the screening program in detecting early-stage lung cancer.

LIVER TRANSPLANTATION (2023)

添加到收藏夹

Article Public, Environmental & Occupational Health

Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness

Xiaohui Zeng, Zhen Zhou, Xia Luo, Qiao Liu

Summary: This study compares the cost-effectiveness of different frequencies of LDCT screening for early detection of lung cancer in the Chinese healthcare system and estimates the associated national healthcare expenditure and five-year LC mortality. The results suggest that annual screening starting at age 50 is the most cost-effective strategy in China.

FRONTIERS IN PUBLIC HEALTH (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Optimum diameter threshold for lung nodules at baseline lung cancer screening with low-dose chest CT: exploration of results from the Korean Lung Cancer Screening Project

Eui Jin Hwang, Jin Mo Goo, Hyae Young Kim, Jaeyoun Yi, Yeol Kim

Summary: Elevating the diameter threshold for solid nodules from 6 to 9 mm may lead to a substantial reduction in unnecessary follow-up LDCTs with a small proportion of diagnostic delay of lung cancers.

EUROPEAN RADIOLOGY (2021)

添加到收藏夹

Article Medicine, General & Internal

Lung Cancer Screening with Low-Dose CT: Radiation Risk and Benefit-Risk Assessment for Different Screening Scenarios

Elke A. Nekolla, Gunnar Brix, Juergen Griebel

Summary: Recent studies have shown that low-dose computed tomography (LDCT) screening can significantly reduce lung cancer mortality in heavy smokers or ex-smokers. However, LDCT screening is associated with radiation risks, and the benefits and risks need to be carefully considered.

DIAGNOSTICS (2022)

添加到收藏夹

Article Medicine, General & Internal

Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China

Zixuan Zhao, Youqing Wang, Weijia Wu, Yi Yang, Lingbin Du, Hengjin Dong

Summary: China has a significant cancer burden, particularly regarding lung cancer, which is the leading cause of cancer-related death. This study compares the cost-effectiveness of low-dose computed tomography (LDCT) with a biomarker (micro-RNA signature classifier) to LDCT alone for lung cancer screening. The results show that China's 2018 recommendation for screening is more cost-effective than the 2021 recommendation, and the cost-effectiveness is further improved when the biomarker is included with LDCT.

JAMA NETWORK OPEN (2022)

添加到收藏夹

Article Critical Care Medicine

One-off low-dose CT for lung cancer screening in China: a multicentre, population-based, prospective cohort study

Ni Li, Fengwei Tan, Wanqing Chen, Min Dai, Fei Wang, Sipeng Shen, Wei Tang, Jiang Li, Yiwen Yu, Wei Cao, Yongjie Xu, Chao Qin, Liang Zhao, Meng Zhu, Lanwei Guo, Zheng Wu, Zhuoyu Yang, Yadi Zheng, Hongda Chen, Yunyong Liu, Donghua Wei, Dong Dong, Ji Cao, Shaokai Zhang, Shipeng Yan, Ning Wang, Lingbin Du, Hongbing Shen, Ning Wu, Jie He

Summary: This study evaluated the effectiveness of one-off low-dose CT (LDCT) screening for the early detection of lung cancer in China. The results showed that one-off LDCT screening significantly reduced lung cancer mortality and all-cause mortality, indicating its potential in countries with limited medical resources.

LANCET RESPIRATORY MEDICINE (2022)

添加到收藏夹

Article Radiology, Nuclear Medicine & Medical Imaging

Deep Learning for Malignancy Risk Estimation of Pulmonary Nodules Detected at Low-Dose Screening CT

Kiran Vaidhya Venkadesh, Arnaud A. A. Setio, Anton Schreuder, Ernst T. Scholten, Kaman Chung, Mathilde M. W. Wille, Zaigham Saghir, Bram van Ginneken, Mathias Prokop, Colin Jacobs

Summary: The deep learning algorithm developed in this study showed excellent performance in estimating the malignancy risk of pulmonary nodules detected at screening CT, outperforming the PanCanadian model in certain cohorts and performing comparably to thoracic radiologists. This algorithm has the potential to provide reliable and reproducible malignancy risk scores for clinicians, which may help optimize management in lung cancer screening.

RADIOLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Development of deep learning-assisted overscan decision algorithm in low-dose chest CT: Application to lung cancer screening in Korean National CT accreditation program

Sihwan Kim, Woo Kyoung Jeong, Jin Hwa Choi, Jong Hyo Kim, Minsoo Chun

Summary: We propose a deep learning-assisted algorithm for overscan decision in chest LDCT for lung cancer screening. The algorithm uses subjective evaluation criteria from radiologists and shows high performance in both internal and external datasets. It presents a reliable alternative to manual evaluation by radiologists.

PLOS ONE (2022)

添加到收藏夹

Review Oncology

Latest CT technologies in lung cancer screening: protocols and radiation dose reduction

Marleen Vonder, Monique D. Dorrius, Rozemarijn Vliegenthart

Summary: This review provides an overview of the evolution of CT protocols in lung cancer screening, emphasizing the reduction of radiation dose and application of dose reduction techniques. Efforts by international radiology organizations to streamline CT data acquisition and image quality assurance are highlighted, along with future perspectives and recommendations for CT lung cancer screening protocols.

TRANSLATIONAL LUNG CANCER RESEARCH (2021)

添加到收藏夹

Article Critical Care Medicine

The Introduction of Low-Dose CT Imaging and Lung Cancer Overdiagnosis in Chinese Women

Mengyan Wang, Shangqun Lin, Na He, Chen Yang, Ruoxin Zhang, Xing Liu, Chen Suo, Tao Lin, Haiquan Chen, Wanghong Xu

Summary: The increasing use of LDCT in low-risk populations in China has led to lung cancer overdiagnosis, especially in women. Criteria for LDCT screening and management of screening-detected nodules need to be addressed for expanded application in China.

CHEST (2023)

添加到收藏夹

Article Biochemical Research Methods

Iam hiQ-a novel pair of accuracy indices for imputed genotypes

Albert Rosenberger, Viola Tozzi, Heike Bickeboeller

Summary: This paper introduces an independent pair of accuracy measures, Iam hiQ, which can be applied to evaluate the output of all imputation software; by applying both measures to a large sample of the International Lung Cancer Consortium (ILCCO), meaningful thresholds for classifying markers of poor accuracy were found.

BMC BIOINFORMATICS (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genome-wide interaction analysis identified low-frequency variants with sex disparity in lung cancer risk

Yafang Li, Xiangjun Xiao, Jianrong Li, Jinyoung Byun, Chao Cheng, Yohan Bosse, James McKay, Demetrios Albanes, Stephen Lam, Adonina Tardon, Chu Chen, Stig E. Bojesen, Maria T. Landi, Mattias Johansson, Angela Risch, Heike Bickeboeller, H-Erich Wichmann, David C. Christiani, Gad Rennert, Susanne Arnold, Gary Goodman, John K. Field, Michael P. A. Davies, Sanjay S. Shete, Loic Le Marchand, Olle Melander, Hans Brunnstrom, Geoffrey Liu, Rayjean J. Hung, Angeline S. Andrew, Lambertus A. Kiemeney, Hongbing Shen, Ryan Sun, Shan Zienolddiny, Kjell Grankvist, Mikael Johansson, Neil Caporaso, Dawn M. Teare, Yun-Chul Hong, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Ann G. Schwartz, Ivan Gorlov, Kristen Purrington, Ping Yang, Yanhong Liu, Younghun Han, Joan E. Bailey-Wilson, Susan M. Pinney, Diptasri Mandal, James C. Willey, Colette Gaba, Paul Brennan, Christopher Amos

Summary: Sex differences in lung cancer risk have not been well studied despite the success in lung cancer association studies. By analyzing genotypes from a lung cancer cohort, we identified three low-frequency variants with differential risk effects in men and women. Further analysis suggested that one of the variants affects lung cancer risk through regulation of CXADR gene expression.

HUMAN MOLECULAR GENETICS (2022)

添加到收藏夹

Article Oncology

Lung Cancer Screening Considerations During Respiratory Infection Outbreaks, Epidemics or Pandemics: An International Association for the Study of Lung Cancer Early Detection and Screening Committee Report

Rudolf M. Huber, Milena Cavic, Anna Kerpel-Fronius, Lucia Viola, John Field, Long Jiang, Ella A. Kazerooni, Coenraad F. N. Koegelenberg, Anant Mohan, Ricardo Sales Dos Santos, Luigi Ventura, Murry Wynes, Dawei Yang, Javier Zulueta, Choon-Taek Lee, Martin C. Tammemagi, Claudia Henschke, Stephen Lam

Summary: This report discusses the importance of global implementation of lung cancer screening and the impact of respiratory infections such as COVID-19 on screening. It highlights the risk of false positive results due to respiratory infections and provides guidance and recommendations for these situations, while also calling for further research and discussions.

JOURNAL OF THORACIC ONCOLOGY (2022)

添加到收藏夹

Article Respiratory System

Selection of eligible participants for screening for lung cancer using primary care data

Emma L. O'Dowd, Kevin Ten Haaf, Jaspreet Kaur, Stephen W. Duffy, William Hamilton, Richard B. Hubbard, John K. Field, Matthew Ej Callister, Sam M. Janes, Harry J. de Koning, Janette Rawlinson, David R. Baldwin

Summary: The effectiveness of lung cancer screening for high-risk individuals is well-established. However, applying risk-prediction models directly to primary care data may not yield accurate results. These models, while helping to reduce the number of individuals for screening evaluation, may also result in missing some cases of lung cancer. Further research is needed to improve the performance of these models in primary care settings.

THORAX (2022)

添加到收藏夹

Article Oncology

Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY)

Ann Olsson, Neela Guha, Liacine Bouaoun, Hans Kromhout, Susan Peters, Jack Siemiatycki, Vikki Ho, Per Gustavsson, Paolo Boffetta, Roel Vermeulen, Thomas Behrens, Thomas Bruening, Benjamin Kendzia, Pascal Guenel, Daniele Luce, Stefan Karrasch, Heinz-Erich Wichmann, Dario Consonni, Maria Teresa Landi, Neil E. Caporaso, Franco Merletti, Dario Mirabelli, Lorenzo Richiardi, Karl-Heinz Joeckel, Wolfgang Ahrens, Hermann Pohlabeln, Adonina Tardon, David Zaridze, John K. Field, Jolanta Lissowska, Beata Swiatkowska, John R. McLaughlin, Paul A. Demers, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Tamas Pandics, Eleonora Fabianova, Dana Mates, Francesco Forastiere, Bas Bueno-de-Mesquita, Joachim Schuez, Kurt Straif

Summary: This study investigated the association between occupational exposure to PAH and lung cancer risk. The results showed an elevated risk of lung cancer among both men and women with PAH exposure. The study also found joint effects between PAH and smoking. However, more recent studies did not show an increased risk of lung cancer associated with PAH.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)

添加到收藏夹

Article Health Care Sciences & Services

Attitudes towards the integration of smoking cessation into lung cancer screening in the United Kingdom: A qualitative study of individuals eligible to attend

Samantha Groves, Grace McCutchan, Samantha L. Quaife, Rachael L. Murray, Jamie S. Ostroff, Kate Brain, Philip A. J. Crosbie, Janelle Yorke, David Baldwin, John K. Field, Lorna McWilliams

Summary: This study explored attitudes and preferences regarding the integration of smoking cessation support within lung cancer screening in the UK. The results showed that the integration of smoking cessation was positively viewed by eligible individuals. Personalized lung health information during screening appointments may increase cessation motivation. Services should support participants with fatalistic views and decreased motivation upon receiving a good screening result. Person-centred services are needed to increase engagement in cessation.

HEALTH EXPECTATIONS (2022)

添加到收藏夹

Article Oncology

A Large-Scale Genome-Wide Gene-Gene Interaction Study of Lung Cancer Susceptibility in Europeans With a Trans-Ethnic Validation in Asians

Ruyang Zhang, Sipeng Shen, Yongyue Wei, Ying Zhu, Yi Li, Jiajin Chen, Jinxing Guan, Zoucheng Pan, Yuzhuo Wang, Meng Zhu, Junxing Xie, Xiangjun Xiao, Dakai Zhu, Yafang Li, Demetrios Albanes, Maria Teresa Landi, Neil E. Caporaso, Stephen Lam, Adonina Tardon, Chu Chen, Stig E. Bojesen, Mattias Johansson, Angela Risch, Heike Bickeboeller, H-Erich Wichmann, Gadi Rennert, Susanne Arnold, Paul Brennan, James D. McKay, John K. Field, Sanjay S. Shete, Loic Le Marchand, Geoffrey Liu, Angeline S. Andrew, Lambertus A. Kiemeney, Shan Zienolddiny-Narui, Annelie Behndig, Mikael Johansson, Angela Cox, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Juncheng Dai, Hongxia Ma, Yang Zhao, Zhibin Hu, Rayjean J. Hung, Christopher Amos, Hongbing Shen, Feng Chen, David C. Christiani

Summary: In this study, important gene-gene interactions that influence the risk of non-small cell lung cancer (NSCLC) were identified and enriched in the 5p15.33 and 6p21.32 regions. These findings have the potential to improve lung cancer screening models.

JOURNAL OF THORACIC ONCOLOGY (2022)

添加到收藏夹

Article Genetics & Heredity

Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer

Jinyoung Byun, Younghun Han, Yafang Li, Jun Xia, Erping Long, Jiyeon Choi, Xiangjun Xiao, Meng Zhu, Wen Zhou, Ryan Sun, Yohan Bosse, Zhuoyi Song, Ann Schwartz, Christine Lusk, Thorunn Rafnar, Kari Stefansson, Tongwu Zhang, Wei Zhao, Rowland W. Pettit, Yanhong Liu, Xihao Li, Hufeng Zhou, Kyle M. Walsh, Ivan Gorlov, Olga Gorlova, Dakai Zhu, Susan M. Rosenberg, Susan Pinney, Joan E. Bailey-Wilson, Diptasri Mandal, Mariza de Andrade, Colette Gaba, James C. Willey, Ming You, Marshall Anderson, John K. Wiencke, Demetrius Albanes, Stephan Lam, Adonina Tardon, Chu Chen, Gary Goodman, Stig Bojeson, Hermann Brenner, Maria Teresa Landi, Stephen J. Chanock, Mattias Johansson, Thomas Muley, Angela Risch, H-Erich Wichmann, Heike Bickeboeller, David C. Christiani, Gad Rennert, Susanne Arnold, John K. Field, Sanjay Shete, Loic Le Marchand, Olle Melander, Hans Brunnstrom, Geoffrey Liu, Angeline S. Andrew, Lambertus A. Kiemeney, Hongbing Shen, Shanbeh Zienolddiny, Kjell Grankvist, Mikael Johansson, Neil Caporaso, Angela Cox, Yun-Chul Hong, Jian-Min Yuan, Philip Lazarus, Matthew B. Schabath, Melinda C. Aldrich, Alpa Patel, Qing Lan, Nathaniel Rothman, Fiona Taylor, Linda Kachuri, John S. Witte, Lori C. Sakoda, Margaret Spitz, Paul Brennan, Xihong Lin, James McKay, Rayjean J. Hung, Christopher Amos

Summary: A genome-wide association meta-analysis of lung cancer among different populations reveals five new susceptibility loci and identifies population-specific effects of common and rare variants. The study also highlights the potential role of genes such as IRF4 and FUBP1 in promoting DNA damage in lung fibroblasts.

NATURE GENETICS (2022)

添加到收藏夹

Article Public, Environmental & Occupational Health

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Hilary A. Robbins, Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed, Matthew T. Warkentin, Karl Smith-Byrne, Yonathan Brhane, David Muller, Xiaoshuang Feng, Demetrius Albanes, Melinda C. Aldrich, Alan A. Arslan, Julie Bassett, Christine D. Berg, Qiuyin Cai, Chu Chen, Michael P. A. Davies, Brenda Diergaarde, John K. Field, Neal D. Freedman, Wen-Yi Huang, Mikael Johansson, Michael Jones, Woon-Puay Koh, Stephen Lam, Qing Lan, Arnulf Langhammer, Linda M. Liao, Geoffrey Liu, Reza Malekzadeh, Roger L. Milne, Luis M. Montuenga, Thomas Rohan, Howard D. Sesso, Gianluca Severi, Mahdi Sheikh, Rashmi Sinha, Xiao-Ou Shu, Victoria L. Stevens, Martin C. Tammemaegi, Lesley F. Tinker, Kala Visvanathan, Ying Wang, Renwei Wang, Stephanie J. Weinstein, Emily White, David Wilson, Jian-Min Yuan, Xuehong Zhang, Wei Zheng, Christopher I. Amos, Paul Brennan, Mattias Johansson, Rayjean J. Hung

Summary: The INTEGRAL program aims to develop tools for optimizing LDCT lung cancer screening. It includes the Risk Biomarker and Nodule Malignancy projects, which investigate circulating protein markers for identifying individuals likely to benefit from screening and distinguishing benign versus malignant nodules. A total of 1161 and 1078 proteins were measured, and 21 proteins were selected for performance evaluation in the Risk Biomarker and Nodule Malignancy projects.

ANNALS OF EPIDEMIOLOGY (2023)

添加到收藏夹

Article Oncology

Occupational exposure to nickel and hexavalent chromium and the risk of lung cancer in a pooled analysis of case-control studies (SYNERGY)

Thomas Behrens, Calvin Ge, Roel Vermeulen, Benjamin Kendzia, Ann Olsson, Joachim Schuez, Hans Kromhout, Beate Pesch, Susan Peters, Luetzen Portengen, Per Gustavsson, Dario Mirabelli, Pascal Guenel, Daniele Luce, Dario Consonni, Neil E. Caporaso, Maria Teresa Landi, John K. Field, Stefan Karrasch, Heinz-Erich Wichmann, Jack Siemiatycki, Marie-Elise Parent, Lorenzo Richiardi, Lorenzo Simonato, Karl-Heinz Joeckel, Wolfgang Ahrens, Hermann Pohlabeln, Guillermo Fernandez-Tardon, David Zaridze, John R. McLaughlin, Paul A. Demers, Beata Swiatkowska, Jolanta Lissowska, Tamas Pandics, Eleonora Fabianova, Dana Mates, Vladimir Bencko, Lenka Foretova, Vladimir Janout, Paolo Boffetta, Bas Bueno-de-Mesquita, Francesco Forastiere, Kurt Straif, Thomas Bruening

Summary: Limited evidence exists regarding the exposure-effect relationship between lung-cancer risk and hexavalent chromium (Cr(VI)) or nickel. This study found that occupational exposure to Cr(VI) and nickel was associated with lung-cancer risks, particularly in men. In men, the highest quartile of cumulative exposure to CR(VI) and nickel were both significantly associated with increased odds ratios for lung cancer.

INTERNATIONAL JOURNAL OF CANCER (2023)

添加到收藏夹

Editorial Material Respiratory System

Road map to improve the quality of lung cancer risk data

John K. Field

THORAX (2023)

添加到收藏夹

Article Medicine, General & Internal

Plasma protein biomarkers for early prediction of lung cancer

Michael P. A. Davies, Takahiro Sato, Haitham Ashoor, Liping Hou, Triantafillos Liloglou, Robert Yang, John K. Field

Summary: The study investigated the potential of plasma proteomes for lung cancer prediction and identified differentially expressed proteins and pathways associated with the presence and prediction of lung cancer.

EBIOMEDICINE (2023)

添加到收藏夹

Review Oncology

Defining the road map to a UK national lung cancer screening programme

Emma L. O'Dowd, Richard W. Lee, Ahsan R. Akram, Emily C. Bartlett, Stephen H. Bradley, Kate Brain, Matthew E. J. Callister, Yan Chen, Anand Devaraj, Sinan R. Eccles, John K. Field, Jesme Fox, Seamus Grundy, Sam M. Janes, Martin Ledson, Melanie MacKean, Anne Mackie, Kieran G. McManus, Rachael L. Murray, Arjun Nair, Samantha L. Quaife, Robert Rintoul, Anne Stevenson, Yvonne Summers, Louise S. Wilkinson, Richard Booton, David R. Baldwint, Philip Crosbie

Summary: Lung cancer screening with low-dose CT has been recommended by the UK National Screening Committee based on trials showing a reduction in lung cancer mortality. The UK has made significant progress in addressing logistical issues and implementing targeted lung cancer screening through clinical trials and the NHS England Targeted Lung Health Check Programme. This Policy Review provides a summary of the consensus and key requirements for effective implementation of a screening programme, and can serve as a valuable resource for countries planning their own lung cancer screenings.

LANCET ONCOLOGY (2023)

添加到收藏夹

Letter Health Care Sciences & Services

Understanding the lung cancer mortality reductions produced by low-dose CT screening-Authors' reply

Stephen W. Duffy, John K. Field

LANCET REGIONAL HEALTH-EUROPE (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer

Albert Rosenberger, Nils Muttray, Rayjean J. Hung, David C. Christiani, Neil E. Caporaso, Geoffrey Liu, Stig E. Bojesen, Loic Le Marchand, Demetrios Albanes, Melinda C. Aldrich, Adonina Tardon, Guillermo Fernandez-Tardon, Gad Rennert, John K. Field, Michael P. A. Davies, Triantafillos Liloglou, Lambertus A. Kiemeney, Philip Lazarus, Bernadette Wendel, Aage Haugen, Shanbeh Zienolddiny, Stephen Lam, Matthew B. Schabath, Angeline S. Andrew, Eric J. Duell, Susanne M. Arnold, Gary E. Goodman, Chu Chen, Jennifer A. Doherty, Fiona Taylor, Angela Cox, Penella J. Woll, Angela Risch, Thomas R. Muley, Mikael Johansson, Paul Brennan, Maria Teresa Landi, Sanjay S. Shete, Christopher Amos, Heike Bickeboeller

Summary: This study assessed the association and predictive ability of AhR/Wnt genes with lung cancer in individuals of European descent. The results showed no genome-wide significant association with overall lung cancer, but significant associations were observed in subgroups of ever smokers and never smokers. Although the predictability is poor, AhR/Wnt variants are overrepresented in optimized prediction scores for lung cancer.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2022)

添加到收藏夹

暂无数据

Mortality Reduction with Low-Dose CT Screening for Lung Cancer

期刊

出版社

MASSACHUSETTS MEDICAL SOC

关键词

类别

资金

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

评论

主要评分

次要评分

新颖性

重要性

科学严谨性

评价这篇论文

推荐

导出引文

分享论文